Related Experiment Video
Updated: Mar 23, 2026
08:02
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
3.0K
[Lysophosphatidic acid and malignant neoplasms]
Postepy Biochemii
|April 7, 2016
Summary
Lysophosphatidic acid (LPA) is a lipid crucial for bodily functions. Research explores LPA
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Lysophosphatidic acid (LPA) is a vital lipid mediator involved in cellular development and function.
- Extracellular LPA is synthesized by autotaxin from lysophospholipids.
- LPA signaling through G protein-coupled receptors influences cell proliferation, migration, and survival.
Purpose of the Study:
- To investigate the role of LPA and its signaling pathways in cellular processes.
- To evaluate the potential of LPA as a diagnostic marker for neoplasms, particularly ovarian cancer.
- To explore the therapeutic potential of LPA inhibitors in cancer treatment.
Main Methods:
- Analysis of LPA signaling pathways and their downstream effects.
- Assessment of autotaxin and LPA receptor expression in various neoplasms.
- Measurement of plasma LPA concentrations in ovarian cancer patients and control groups.
- Preclinical evaluation of LPA-inhibiting compounds.
Main Results:
- LPA activation of G protein-coupled receptors leads to increased production of VEGF, MMP, and uPA.
- Aberrant expression of LPA receptors and autotaxin is observed in various cancers.
- Significantly elevated plasma LPA levels were detected in ovarian cancer patients compared to controls.
- Preclinical studies show promising results for LPA-targeting cancer therapies.
Conclusions:
- LPA plays a significant role in cell behavior and is implicated in cancer development.
- LPA shows potential as a diagnostic biomarker for ovarian cancer.
- Inhibitors targeting LPA signaling represent a promising therapeutic strategy for cancer treatment.
More Related Videos
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
629
08:49Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
4.7K
Related Concept Videos
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
01:42Phosphoinositides and PIPs
10.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.5K
01:22PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
02:30Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K